Fig. 3
Re-docking the most active anti-inflammatory compounds 10, 3, 5, 9, 2, and 7 poses compared with flurbiprofen at active COX-2 site.
Fig. 3 | Scientific Reports
Re-docking the most active anti-inflammatory compounds 10, 3, 5, 9, 2, and 7 poses compared with flurbiprofen at active COX-2 site.
